All Episodes

AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

Genitourinary Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting

Metastatic Bladder Cancer — Rapid Case Review Issue 6

Metastatic Bladder Cancer — Rapid Case Review Issue 5

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay

For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress

Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances

Prostate Cancer — Fifth Annual National General Medical Oncology Summit

Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit

Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting

Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting

Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

Metastatic Bladder Cancer — Rapid Case Review Issue 4

AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium

Metastatic Bladder Cancer — Rapid Case Review Issue 3

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium

Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review

Metastatic Bladder Cancer — Rapid Case Review Issue 2

Prostate Cancer — Microlearning Activity 2 with Dr Rana R McKay: ESMO Congress 2025 Review

Urothelial Bladder Cancer — Microlearning Activity 1 with Dr Terence Friedlander: ESMO Congress 2025 Review

Prostate Cancer — Microlearning Activity 1 with Dr Rana R McKay: ESMO Congress 2025 Review

Metastatic Bladder Cancer — Rapid Case Review Issue 1

Urothelial Bladder Cancer and Prostate Cancer — Highlights from the 2025 ESMO Annual Meeting

Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management

Oncology Nursing Update: Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient Care

Renal Cell Carcinoma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

For Oncology Nurses: Prostate Cancer — Proceedings from the 2025 Annual ONS Congress

Urothelial Bladder Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Prostate Cancer  — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting

Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit

Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

Prostate Cancer — Fourth Annual National General Medical Oncology Summit

Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates

Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)

Urothelial Bladder Cancer and Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Prostate Cancer

Oncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder Cancer

Oncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer

Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review

Oncology Today with Dr Neil Love: Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer

Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

Oncology Today with Dr Neil Love: Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer

Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer

Virtual Case Library: Metastatic Urothelial Bladder Cancer

Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer

Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer

Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer

Management of Urothelial Bladder Cancer with Dr Matthew Galsky

Oncology Today with Dr Neil Love: Special Edition — What I Tell My Patients About New Treatments and Clinical Trials in Urothelial Bladder Cancer

Investigator Perspectives on Available Research Findings and Challenging Questions in Renal Cell Carcinoma

What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Urothelial Bladder Cancer

Oncology Today: Recent Research Advances in Prostate Cancer and the Clinical Implications – A 2023 Post-ASCO GU Activity

Oncology Today with Dr Neil Love: Special Edition — Recent Research Advances in Prostate Cancer and the Clinical Implications (Faculty Interview)

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Renal Cell Carcinoma and Bladder Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer

Recent Advances and Future Directions in Genitourinary Cancers — With Dr Daniel Petrylak and Dr Sandy Srinivas (Proceedings from a Symposium in Partnership with NCOA and SCOS)

Oncology Today with Dr Neil Love: Managing Metastatic Urothelial Bladder Cancer

Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 2 of a 2-Part Series

Oncology Today with Dr Neil Love: Management of Renal Cell Carcinoma

The Clinical Implications of Key Recent Data Sets in Prostate and Bladder Cancers — With Drs Alicia Morgans and Evan Yu (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)

The Clinical Implications of Key Recent Data Sets in Renal Cell Carcinoma — With Prof Thomas Powles (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)

Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 1 of a 2-Part Series

Oncology Today with Dr Neil Love: Neuroendocrine Tumors